2-(1-Methylguanidino)acetic acid

Catalog No.: 
ACKNEU853
CAS No.: 
57-00-1
Molecular Formula: 
C4H9N3O2
Molecular Weight: 
131.13
2-(1-Methylguanidino)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1000g95%$70.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1-Methylguanidino)acetic acid
IUPAC NameN-carbamimidoyl-N-methylglycine
MDL No.MFCD00004282
Molecular FormulaC4H9N3O2
Molecular Weight131.13
SMILESO=C(O)CN(C)C(N)=N
InChI KeyCVSVTCORWBXHQV-UHFFFAOYSA-N
Synonymcreatine | 57-00-1 | Creatin | Kreatin | N-amidinosarcosine | Krebiozon | N-methyl-N-guanylglycine | 2-(1-Methylguanidino)acetic acid | methylglycocyamine | Creatine, hydrate | Glycine, N-(aminoiminomethyl)-N-methyl- | Pyrolysate | (alpha-Methylguanido)acetic acid | Cosmocair C 10
CAS No.57-00-1
PubChem CID586

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKNEU853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  2. Then
  3. ACKNEU853 route product structure diagram
    ACKNEU85357-00-1In Stock
Inquiry

2. ACKNEU853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLGOT697 route compound structure diagram
    ACLGOT69760-27-5In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Then
  5. ACKNEU853 route product structure diagram
    ACKNEU85357-00-1In Stock
Inquiry

3. ACKNEU853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKXR028 route compound structure diagram
    ACCKXR02871519-72-7In Stock
  2. Then
  3. ACKNEU853 route product structure diagram
    ACKNEU85357-00-1In Stock
Inquiry

Comments (0)